Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0TC5H
|
|||
Former ID |
DNC010265
|
|||
Drug Name |
3-(6-morpholino-9H-purin-2-yl)phenol
|
|||
Synonyms |
3-(6-morpholino-9H-purin-2-yl)phenol; CHEMBL593515; SCHEMBL4443377; FUDQNOGEMXSUSQ-UHFFFAOYSA-N
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H15N5O2
|
|||
Canonical SMILES |
C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC(=CC=C4)O
|
|||
InChI |
1S/C15H15N5O2/c21-11-3-1-2-10(8-11)13-18-14-12(16-9-17-14)15(19-13)20-4-6-22-7-5-20/h1-3,8-9,21H,4-7H2,(H,16,17,18,19)
|
|||
InChIKey |
FUDQNOGEMXSUSQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studies. Bioorg Med Chem Lett. 2010 Jan 15;20(2):636-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.